Expert Outlook: Fate Therapeutics Through The Eyes Of 9 Analysts
Expert Outlook: Fate Therapeutics Through The Eyes Of 9 Analysts
九位分析師眼中的fate therapeutics專家展望
Across the recent three months, 9 analysts have shared their insights on Fate Therapeutics (NASDAQ:FATE), expressing a variety of opinions spanning from bullish to bearish.
在最近的三個月中，有9位分析師分享了他們對Fate Therapeutics（納斯達克股票代碼：FATE）的見解，從看好到看淡都有。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他們最近的評級，展示了過去30天內的情緒演變並與之前的幾個月進行了比較。
Analysts have set 12-month price targets for Fate Therapeutics, revealing an average target of $6.11, a high estimate of $9.00, and a low estimate of $4.00. This current average has decreased by 6.0% from the previous average price target of $6.50.
分析師爲Fate Therapeutics設定了爲期12個月的目標股價，揭示了平均目標爲6.11美元，最高預估爲9.00美元，最低預估爲4.00美元。當前平均目標股價比上一平均價格目標下降了6.0%。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：更深入的了解
In examining recent analyst actions, we gain insights...
通過檢查最近的分...
登入免費觀看全文
登入/註冊